Eurofins BioPharma Services Newsletter 28 - 2021

Eurofins presenta la nuova edizione della newsletter BioPharma NEWS.
Articoli contenuti:
- Eurofins Viracor BioPharma partners with Moderna, performing essential clinical trial testing for COVID-19 Vaccine
- Eurofins holds a wealth of cGMP experience testing RNA based drugs
- Eurofins Bioanalytical Services develops surrogate virus neutralising antibody detection assays against SARS-CoV-2
- Targeting pro-inflammatory cytokines for COVID-19 therapy: Qualified cell-based assays for accelerated drug discovery
- Eurofins launches new tests and massive capacity to detect and monitor new variants of SARS-CoV-2
- Testing disinfectants for virucidal efficacy, a daily job at Eurofins
> Scarica la newsletter in formato PDF
Cordiali saluti.
Il comitato editoriale del gruppo Eurofins.